Antharis Therapeutics Revenue

Biotechnology Research • Vista, California, United States • 11-20 Employees

Antharis Therapeutics revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	No funding

Key Contact at Antharis Therapeutics

Mary Dwyer

Director Of Research & Development

Company overview

Headquarters	Vista, California, United States
Phone number	+12347658970
Website	antharistherapeutics.com
Keywords	Biotechnology, Pharmaceutical, Oncology, Biotech, Cancer, Neurology, Antibodies, Breast Cancer, Therapies, Brain Cancer, Leukemia, Lymphoma, Cancer Biology, Biopharma, Bispecific Antibodies, Monoclonal Antibodies, Colorectal Cancer, Solid Tumor, Antibody Drug Conjugates, Therapeutic Antibodies, Pan Cancer
Founded	2020
Employees	11-20
Socials

Antharis Therapeutics Email Formats

Antharis Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@antharistherapeutics.com), used 63.2% of the time.

Format	Example	Percentage
{first initial}	j@antharistherapeutics.com	63.2%
{first name}	john@antharistherapeutics.com	36.8%

About Antharis Therapeutics

Antharis Therapeutics is a multinational biopharmaceutical company developing new treatments for cancer and inflammatory diseases. In particular, our company utilizes cutting-edge science to develop next-generation therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs. The company, founded by Dr. Raphael R Pinaud in 2020, has significantly grown and successfully advanced its mission to date. Furthermore, Antharis strategically acquired Cassyni Biopharma and Galileo Biotech, in mid-2022 and mid-2023, respectively, to further and more effectively advance its mandate to bring transformational therapies to patients in need. Antharis has built an extensive pipeline of innovative therapies and, through pioneering research, is poised to initiate clinical trials in 2025 with several of its assets, making significant strides toward addressing unmet oncology needs.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Senior

Employees by Department

Antharis Therapeutics has 7 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Antharis Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-02-01	3	N/A

Funding Insights

Number of funding rounds

Antharis Therapeutics Tech Stack

Discover the technologies and tools that power Antharis Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery CDN

CDN

reCAPTCHA

Security

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Webflow

Page builders

IONOS

Hosting

Cloudflare Turnstile

Security

Google Font API

Font scripts

Frequently asked questions

Antharis Therapeutics is located in Vista, California, US.

You can reach Antharis Therapeutics at +12347658970.

Antharis Therapeutics generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.

Antharis Therapeutics has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Antharis Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Antharis Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Antharis Therapeutics

Mary Dwyer

Director Of Research & Development

4.8

40,000 users